ARCHIVES

Nexavar Improves PFS In HER-2 Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 5 | May 27, 2011

Download PDF Visit The Full Archive

Related Articles

Appropriations: NIH Professional Needs Budget Gains Attention

March 14, 1997

Limit On Number Of Surgery Planning Grants Lifted After DCT Board Pressure

March 19, 1982

Letter to the Editors: BSA P01 Review Vote Was Advisory, NCI Official Says

December 5, 1997

CAP, ASCCP Recommendations Standardize Lesion Terminology

July 27, 2012

SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma

September 29, 2006

NCAB Committee Approves NCI Plans For Organ Systems

February 5, 1988